The Bloomberg American Health Initiative at the Johns Hopkins Bloomberg School of Public Health announces its 2020 cohort of Bloomberg Fellows, each drawn from an organization working on one of five critical health challenges facing the nation: addiction and overdose, environmental challenges, obesity and the food system, adolescent health, and violence.
Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.
Shelley Hearne, DrPH, MPH, has joined the Johns Hopkins Bloomberg School of Public Health as the new director of the Johns Hopkins Center for Public Health Advocacy and the inaugural Alfred Sommer and Michael Klag Decanal Professor of the Practice for Public Health Advocacy.
To address the nationwide shortage of specialized nasal swabs used for COVID-19 diagnoses, Lawrence Livermore National Laboratory engineers formed an ad hoc, rapid response team that tested more than a dozen novel, 3D-printed swab designs from a grassroots coalition of commercial and academic partners. The mechanical tests performed at the Lab provided valuable feedback that improved the designs, enabling them to meet requirements for COVID-19 testing. The Lab’s work on swabs is continuing with funding from the U.S. Department of Energy (DOE) and expanding into other 3D-printed components for COVID-19 test kits.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) and colleagues reported today in Science two studies of laboratory monkeys that suggest antibodies produced during recovery from COVID-19 provide immunity from the virus, whether triggered by infection or vaccine.
Oprah Winfrey Charitable Foundation has donated $5M to accelerate Rush and West Side United-led efforts to help West Side neighborhoods prevent and battle COVID-19
In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.
Lifesaving innovations for COVID-19 will only markedly increase the already existing racial inequalities, if public health initiatives for equitable dissemination throughout all communities are not immediately developed. The introduction of drugs for HIV, respiratory distress syndrome, and hepatitis C resulted in racial inequalities. Moreover, before the introduction of the Salk polio vaccine in 1952, initially, black Americans experienced significantly lower rates of paralytic polio than white Americans. By 1959, after the widespread distribution of the vaccine, the reverse was true.
Fewer people than previously reported suffer from stroke as a result of COVID-19, a new analysis finds. However, strokes that accompany the pandemic virus, SARS-CoV-2, appear to be more severe.
Teens are missing out on once-in-a-lifetime milestones like prom and graduation. Our expert offers advice on how to help teens cope with their sadness and grief.
ANN ARBOR—Businesses across the nation are preparing to start reopening their workplaces. Rick Neitzel, an expert on occupational and environmental health at the University of Michigan’s School of Public Health, outlines five steps that employers and employees can take together to return to work in the safest manner possible.
In the midst of the global pandemic, a student at Binghamton University, State University of New York is helping India keep track of COVID-19 infection rates.
The Emergency Medical Services (EMS) Committee of the Conference of Boston Teaching Hospitals is pleased to join our hospital Emergency Medicine colleagues, the American College of Emergency Physicians, the National Association of EMT’s, Governor Charles D. Baker and Lieutenant Governor Karyn Polito, and City of Boston Mayor Martin J. Walsh in celebrating National EMS Week 2020, commencing May 17th, 2020.
The Johns Hopkins Bloomberg School of Public Health recognized graduates of the Class of 2020 in a pre-recorded Convocation ceremony broadcast yesterday.
As a result of the COVID-19 pandemic many radiology departments have experienced a rapid decline in imaging case volumes. This new study, funded by the Harvey L. Neiman Health Policy Institute and published online in Journal of the American College of Radiology (JACR), evaluates the impact of the pandemic on imaging case volumes using real-world data from a large healthcare institution.
One of the many unanswered scientific questions about COVID-19 is whether it is seasonal like the flu – waning in warm summer months then resurging in the fall and winter. Now scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) are launching a project to apply machine-learning methods to a plethora of health and environmental datasets, combined with high-resolution climate models and seasonal forecasts, to tease out the answer.
The Integrated Translational Health Institute of Virginia (iTHRIV) has developed an online tool to collect COVID-19 information from volunteers who live in Virginia.
The public have massive trust in the NHS, who should have control and access to data in the Covid-19 contact-tracing app, according to new research by researchers in WMG at the University of Warwick, and at the University of Birmingham.
NCCN and the NCCN Foundation announce five new recipients for the 10th annual NCCN Foundation Young Investigator Awards (YIA) Program, overseen by the NCCN Oncology Research Program (ORP)
• Around 70% of young people who report self-harming or suicidal thoughts are within normal or non-clinical range of mental distress. • First study to suggest ‘prevention paradox’ in mental health: tiny wellbeing improvements in entire populations will save as many if not more lives than focusing on high-risk groups.
An alternating cycle of 50 days of strict lockdown followed by 30 days of easing could be an effective strategy for reducing the number of COVID-19-related deaths and admissions to intensive care units, say an international team of researchers.
Comprehensive implementation of COVID-19 infection prevention measures boosts their effectiveness, while partial implementation compromises it.
- Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution - Scaled kit production to enable clinical laboratories to conduct 10M tests per month is planned to begin in July
COVID-19 is associated with a high incidence of venous thromboembolism, blood clots in the venous circulation, according to a study conducted by researchers at Brighton and Sussex Medical School (BSMS), UK.
As millions continue working from home during the pandemic or are required to report to jobs as essential employees, many have raised questions about how these work conditions impact our health -- and not just as they relate to COVID-19. A new study from the Indiana University Kelley School of Business finds that our mental health and mortality have a strong correlation with the amount of autonomy we have at our job, our workload and job demands, and our cognitive ability to deal with those demands.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 i
Irvine, Calif., May 19, 2020 – A new weapon in the arsenal against the coronavirus may be sitting in your home entertainment console. A team led by physicist Chris Barty of the University of California, Irvine is researching the use of diodes from Blu-ray digital video disc devices as deep-ultraviolet laser photon sources to rapidly disinfect surfaces and the indoor air that swirls around us.
More precise data has informed a second modeling study produced by the University of Louisville School of Public Health and Information Sciences (SPHIS) and the Louisville Metro Department of Public Health & Wellness (LMPHW).
Seeing someone do something good for someone else motivates witnesses to perform their own helpful acts, an insight that could help drive cooperative behavior in communities navigating through the health crisis.
While it’s too soon to use COVID-19 antibody testing to issue “immunity passports”, antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.
Real-time data about health and health care during the COVID-19 pandemic can help contain the virus but has been difficult to obtain. A new paper published in JAMA explores the concept of a national health information technology (IT) infrastructure to provide up-to-date patient information in public health emergencies, which can then be used in planning and containment efforts.
As the virus causing COVID-19 began its devastating spread, an international team of scientists was alarmed by the lack of uniform approaches by various countries’ epidemiologists. Data modeling to predict the numbers of likely infections varied widely and revealed a high degree of uncertainty. In the journal Chaos, the group describes why modeling and extrapolating the evolution of COVID-19 outbreaks in near real time is an enormous scientific challenge that requires a deep understanding of the nonlinearities underlying the dynamics of epidemics.
For this 2020 World No Tobacco Day, experts from the Rutgers Tobacco Dependence Program discuss New Jersey quit centers and how quitting tobacco can benefit one during cancer treatment.
An antibody derived from a SARS survivor in 2003 appears to effectively neutralize the coronavirus that causes COVID-19, opening the door for speedy development of a targeted treatment.
It seems like there will never be enough “thank you’s” for the incredible doctors, nurses technicians and support staff members who are working around the clock to help patients with this dangerous disease. It is their dedication, determination and spirit that allow Johns Hopkins to deliver the promise of medicine.
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.
Mount Sinai researchers are the first in the country to use artificial intelligence (AI) combined with imaging, and clinical data to analyze patients with coronavirus disease (COVID-19).
Three drugs that are already approved by the Food and Drug Administration (FDA) or other international agencies can block the production of the novel coronavirus that causes COVID-19 in human cells, according to computational and pharmaceutical studies performed by UT Southwestern scientists.
Alessandro Rebucci, an economist and associate professor at Johns Hopkins Carey Business School, has analyzed the impact of current health interventions to stop COVID-19 as well as lessons learned from previous economic crises. He offers important insights for policymakers.
Becky Liu-Lastres, assistant professor in the Department of Tourism, Event, and Sport Management at IUPUI is available to talk about COVID-19’s potential impact on vacations this summer, particularly how tourists will make travel decisions based on their perceived risk and how that affects small businesses in particular.
To ensure the proper use of antibody testing for the novel coronavirus, AACC today issued a public statement detailing the role these tests should play in the management of COVID-19 patients and in the development of public health policy. In particular, the organization emphasizes that healthcare professionals and policymakers should work closely with laboratory experts on antibody testing to ensure that these tests are validated, used appropriately, and interpreted correctly.
In an upcoming study to be published in Gastroenterology, researchers at the Icahn School of Medicine at Mount Sinai and the University of North Carolina School of Medicine report on the clinical course of COVID-19 and risk factors for adverse outcomes in a large cohort of patients with IBD collected through an international registry.
Notre Dame's Merlin Bruening and a team of scientists have begun research to develop point-of-care antibody tests that would help public health officials to better understand how an individual’s immunity to COVID-19 lasts over time.
The new UW study found the national rate of death among people infected with the novel coronavirus — SARS-CoV-2 — that causes COVID-19 and who show symptoms is 1.3%, the study found. The comparable rate of death for the seasonal flu is 0.1%.
David Peabody, PhD, and Bryce Chackerian, PhD, are creating vaccines from particles that are the opposite of Trojan Horses: they look deadly on the outside but are harmless on the inside. Their virus-like particles may rouse the immune system into combatting COVID-19. The idea is to trick the body into believing it’s been infected with a microscopic foe.
WASHINGTON, DC (May 18, 2020)—Researchers at the George Washington University (GW) recently launched a global survey of health care workers on the frontlines of the COVID-19 pandemic with the hope of learning more about exposure and finding solutions to help protect workers from the virus.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right